Influx Healthtech Limited (NSE:INFLUX)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Neutraceuticals	932.11M
Neutraceuticals Growth	30.21%
Cosmetics	30.07M
Cosmetics Growth	41.87%
Ayurvedic	19.31M
Ayurvedic Growth	10.14%
Petcare	8.78M
Petcare Growth	115.12%
Homecare	6.83M
Homecare Growth	316.22%
Export	2.56M
Export Growth	944.08%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
India	997.09M
India Growth	31.14%
International	2.56M
International Growth	944.08%